Growing the ARR/Share from $1.04 to $5.30 (as of June 30, 2024) with line of sight to >$8. Inflecting to profitability (while not yet reported, I think it happened in Q3 of this year). This is a ...
EPUT is a key contributor to the Lampard Inquiry – the first public inquiry specifically looking to understand what happened to patients who died at children and adult inpatient units under the care ...
Oppenheimer Asset Management came out on Thursday and detailed two buying opportunities and one selling opportunity according to its technical and fundamental research.